The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
Open accessAbstract
Recent literature suggested that cells of the microenvironment of tumors could be abnormal as well. To address this hypothesis in multiple myeloma (MM), we studied bone marrow mesenchymal stem cells (BMMSCs), the only long-lived cells of the bone marrow microenvironment, by gene expression profiling and phenotypic and functional studies in three groups of individuals: patients with MM, patients with monoclonal gamopathy of undefined significance (MGUS) and healthy age-matched subjects. Gene expression profile independently classified the BMMSCs of these individuals in a normal and in an MM group. MGUS BMMSCs were interspersed between these two groups. Among the 145 distinct genes differentially expressed in MM and normal BMMSCs, 46% may account for a tumor-microenvironment cross-talk. Known soluble factors implicated in MM pathophysiologic features (i.e. IL (interleukin)-6, DKK1) were revealed and new ones were found which are involved in angiogenesis, osteogenic differentiation or tumor growth. In particular, GDF15 was found to induce dose-dependent growth of MOLP-6, a stromal cell-dependent myeloma cell line. Functionally, MM BMMSCs induced an overgrowth of MOLP-6, and their capacity to differentiate into an osteoblastic lineage was impaired. Thus, MM BMMSCs are abnormal and could create a very efficient niche to support the survival and proliferation of the myeloma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secretion of elevated levels of IL-6 by MSC has been detected upon interaction with malignant cells in several epithelial, hematopoietic and mesenchymal cancers (Table 2) [43, 69, 76, 77, 82, 115–119].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Notably, MM-MSCs have different gene profiles from their counterparts in normal MSCs [289, 290].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [289]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Self-citationStromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,354
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,330
Ttal, M. I. A., Ean, J., Dünne, A. A., Toppa, A. S., Ossi, R. G., Hilippe, P., Asassus, C., Acon, T. H. F., Orbert, N., Ayen, C. A. P., et al. (2013) · Cited by 2,161
Gregory, C. A., Gunn, W., Peister, A., & Prockop, D. J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.02.002 · Cited by 1,568
Tian, E., Zhan, F., Walker, R. C., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,505
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Harousseau, J.-L., Facon, T., Guilhot, F., Doyen, C., Fuzibet, J.-G., Monconduit, M., Hulin, C., Caillot, D., Bouabdallah, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032290 · Cited by 984
Self-citationSingle versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
(2004) · New England Journal of Medicine · doi:10.1056/nejm200406173502526 · Cited by 817
Cited by
Sorted by citations
Items 301–331 of 331
Targeting Galectin-3 Unveils the Complexity of Multiple Myeloma: A Sweet Context
Mirandola, L., Yu, Y., John, C. M., Jenkins, M., Cobos, E., & Chiriva‐Internati, M. (2012) · ACS symposium series · doi:10.1021/bk-2012-1115.ch017
Véronique-Baudin, J., Pierre-Louis, O., Smith‐Ravin, J., Vestris, M., Rose, M., Méniane, J.-C., Macni, J., Joachim, C., Escarmant, P., & Pierre-Louis, M.-S. (2015) · WIMJ Open · doi:10.7727/wimjopen.2015.423
Mesenchymal Stem/Stromal Cell Trafficking and Homing
Kamdje, A. H. N., Vecchio, L., Etet, P. F. S., Kamga, P. T., Jm, M., Bassi, G., Lukong, E., Goel, R. K., & Krampera, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00007-0
Mahtouk, K., Vos, J. D., Moreaux, J., Jourdan, M., Baudard, M., Rossi, J. F., Reme, T. X., & Klein, B. (2016)
Self-citationTumangelova-Yuzeir, K. D., Ivanova‐Todorova, E., Naydenov, E., Velikova, T. V., Krasimirova, E., Belemezova, K., Dikov, T. I., Penkov, M., Nachev, S., Genova, M., et al. (2018) · Europe PMC (PubMed Central)
Proteasome Inhibitors with a Focus on Bortezomib
Barley, K. M., & Parekh, S. S. (2018) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-75184-9_3
Lewis, K. T., & MacDougald, O. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00004-x
Patra, S. S. (2020) · doi:10.37421/2168-9547.2020.09.250
3D Culture o Multiple Myeloma Cell Line Using Microgel Environments
Marín-Payá, J. C. (2021) · doi:10.4995/thesis/10251/167427
Grassinger, J., & Schelker, R. C. (2013) · Springer eBooks · doi:10.1007/978-94-007-6866-6_6
Terpos, E., & Ntanasis‐Stathopoulos, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00169-2
Rôle du système IGF-1/insuline dans le Myélome Multiple
Sprynski, A. C. (2009) · HAL
Lu, Y., Zheng, C., Zhang, W., Liu, X., Zhou, Z., Wang, Z., Hua, H., Song, Z., Zhang, X., Liu, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26698889
Lu, Y., Zheng, C., Zhang, W., Liu, X., Zhou, Z., Wang, Z., Hua, H., Song, Z., Zhang, X., Liu, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26698886
Lu, Y., Zheng, C., Zhang, W., Liu, X., Zhou, Z., Wang, Z., Hua, H., Song, Z., Zhang, X., Liu, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26698895
Lu, Y., Zheng, C., Zhang, W., Liu, X., Zhou, Z., Wang, Z., Hua, H., Song, Z., Zhang, X., Liu, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26698892
Dash, A., Sachdeva, M. U. S., Mallik, N., Sreedharanunni, S., Luthra‐Guptasarma, M., & Malhotra, P. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156404
Ingangi, V., Amoroso, D., Passaro, E., Vaia, V. D., Maltoni, F., Narimanfar, G., Minopoli, M., Rosa, R., Ametrano, M., Gennaro, E. D., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1741794 · Cited by 1
Escobar, P. A. (2010) · theses.fr (ABES) · doi:10.70675/6ef77dc7ze8f2z4d7bza761zc1f42658f0a5
Kassambara, A. (2011) · theses.fr (ABES) · doi:10.70675/e5a8b7d4z896az46a0z824dz206bef69e01a
Biologie de syndecan-1 au cours du myélome multiple : synthèse, modifications et inhibition
Bret, C. (2010) · theses.fr (ABES) · doi:10.70675/c101a568zdc59z4ae3zb57azfc0925716f49
Li, H., Kong, D., Liu, X., Li, X., Zhao, Y., Wang, Y., Li, S., Hu, J., Chen, Y., Jiang, Y. Z., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202504816r
Ruer, A., Morckhoven, D. V., Pieters, K., Meuleman, N., Lagneaux, L., & Stamatopoulos, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1919303
A 3D engineered multiple myeloma niche for evaluating CAR T cell therapy
Jordana-Urriza, L., Muraro, M. G., Du, M., Lambrecht, V., Rodríguez-Madoz, J. R., Martín, I., & García‐García, A. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1860416
Sitzia, C., Manferdini, C., D’Atri, G., Lisignoli, G., Dessena, M., Giuliani, N., & Storti, P. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1954766
Metadata
- Authors
- Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., Danho, C., Laharrague, P., Klein, B., Rème, T., & Bourin, P.
- Affiliations
- Établissement Français du Sang (FR)
- Inserm (FR)
- Hôpital Purpan (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Bourin, P
- Venue
- Leukemia
- Published
- 2007-03-08
- Volume
- 21
- Issue
- 5
- Pages
- 1079-1088
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- PMC
- PMC2346535
- OpenAlex
- W2048064990
- Cited by
- 328
- References
- 62
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 18 · 2019: 10 · 2018: 18 · 2017: 21 · 2016: 21 · 2015: 18 · 2014: 23 · 2013: 25 · 2012: 25
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple myeloma, bone marrow mesenchymal stem cells, tumor microenvironment, monoclonal gammopathy of undetermined significance, gene expression profiling, interleukin-6, DKK1, GDF15, angiogenesis, osteogenic differentiation
- MeSH terms
- Adult, Aged, Bone Marrow Cells, Cell Differentiation, Female, Hematopoiesis, Humans, Male, Middle Aged, Multiple Myeloma, Osteoblasts, Cytokines, Gene Expression Profiling, Cell Proliferation, Growth Differentiation Factor 15, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
